Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial
2019
Introduction:
Rasagiline is an MAO-B inhibitor with possible neuroprotective effects in patients with amyotrophic lateral sclerosis (ALS).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
48
References
21
Citations
NaN
KQI